SEC 13F Intelligence

Taal Capital Management LP / ALXN

Taal Capital Management LP’s Alexion Pharmaceuticals Inc Position

Does Taal Capital Management LP own Alexion Pharmaceuticals Inc (ALXN)? Yes50.0K shares worth $9M (+7.52% of its 13F portfolio) as of Q2 2021.

Position Value
$9M
Q2 2021
Shares
50.0K
% of Portfolio
+7.52%
Quarters Held
1
currently held

Position History ALXN

Reported value by quarter
Q2 ’21: $9MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202150.0K$9M+7.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Taal Capital Management LP’s full portfolio or all institutional holders of ALXN.